Annual Shareholders Equity
-$4.74 M
-$13.04 M-157.08%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual stockholders equity is -$4.74 million, with the most recent change of -$13.04 million (-157.08%) on December 31, 2023.
- During the last 3 years, EVAX annual shareholders equity has fallen by -$11.78 million (-167.33%).
- EVAX annual shareholders equity is now -114.61% below its all-time high of $32.44 million, reached on December 31, 2021.
Performance
EVAX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$74.00 K
-$1.18 M-94.09%
September 1, 2024
Summary
- As of February 7, 2025, EVAX quarterly stockholders equity is $74.00 thousand, with the most recent change of -$1.18 million (-94.09%) on September 1, 2024.
- Over the past year, EVAX quarterly shareholders equity has increased by +$89.84 million (+100.08%).
- EVAX quarterly shareholders equity is now -99.77% below its all-time high of $32.44 million, reached on December 31, 2021.
Performance
EVAX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EVAX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -157.1% | +100.1% |
| 3 y3 years | -167.3% | -99.8% |
| 5 y5 years | -409.0% | -99.0% |
EVAX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -114.6% | at low | -99.8% | +100.1% |
| 5 y | 5-year | -114.6% | at low | -99.8% | +100.1% |
| alltime | all time | -114.6% | at low | -99.8% | +100.1% |
Evaxion Biotech A/S Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $74.00 K(-94.1%) |
| Jun 2024 | - | $1.25 M(-77.4%) |
| Mar 2024 | - | $5.53 M(-216.8%) |
| Dec 2023 | -$4.74 M(-157.1%) | -$4.74 M(-94.7%) |
| Sep 2023 | - | -$89.76 M(-3640.9%) |
| Jun 2023 | - | $2.54 M(-103.2%) |
| Mar 2023 | - | -$78.72 M(-1048.1%) |
| Dec 2022 | $8.30 M | $8.30 M(-112.6%) |
| Sep 2022 | - | -$65.76 M(-426.4%) |
| Jun 2022 | - | $20.15 M(-23.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $26.39 M(-18.6%) |
| Dec 2021 | $32.44 M(+360.9%) | $32.44 M(+94.8%) |
| Sep 2021 | - | $16.65 M(-23.7%) |
| Jun 2021 | - | $21.83 M(-21.5%) |
| Mar 2021 | - | $27.80 M(+295.0%) |
| Dec 2020 | $7.04 M(-24.8%) | $7.04 M(-10.9%) |
| Sep 2020 | - | $7.90 M(-15.6%) |
| Dec 2019 | $9.36 M(-1105.6%) | $9.36 M |
| Dec 2018 | -$931.00 K(-136.5%) | - |
| Dec 2017 | $2.55 M | - |
FAQ
- What is Evaxion Biotech A/S annual stockholders equity?
- What is the all time high annual shareholders equity for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual shareholders equity year-on-year change?
- What is Evaxion Biotech A/S quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S quarterly shareholders equity year-on-year change?
What is Evaxion Biotech A/S annual stockholders equity?
The current annual shareholders equity of EVAX is -$4.74 M
What is the all time high annual shareholders equity for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual stockholders equity is $32.44 M
What is Evaxion Biotech A/S annual shareholders equity year-on-year change?
Over the past year, EVAX annual stockholders equity has changed by -$13.04 M (-157.08%)
What is Evaxion Biotech A/S quarterly stockholders equity?
The current quarterly shareholders equity of EVAX is $74.00 K
What is the all time high quarterly shareholders equity for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly stockholders equity is $32.44 M
What is Evaxion Biotech A/S quarterly shareholders equity year-on-year change?
Over the past year, EVAX quarterly stockholders equity has changed by +$89.84 M (+100.08%)